Taking Amlodipine, Lisinopril or Metoprolol After 60? Here's The Side Effect Each One Hides

Millions of adults over 60 take amlodipine, lisinopril or metoprolol. There's no single safest pill, but each one has a side effect that often gets blamed on age, one can set off a chain of extra prescriptions, and one is no longer a first choice for plain high blood pressure. Here's what the research and the 2025 guideline say, and the questions to ask your doctor. In this video, we go through the published research and the official guidelines, in plain language, so you can have a better conversation with your doctor. In this video you'll learn: • Why treating blood pressure still matters at 75+ (the SPRINT trial) and the 2025 guideline target • How the three families work: calcium channel blockers, ACE inhibitors and beta-blockers • What ALLHAT, the 33,000-person head-to-head trial, found • Amlodipine: dose-related ankle swelling and the 'prescribing cascade' (JAMA Internal Medicine 2020) • Lisinopril: the dry cough people don't connect, angioedema, potassium and the 'triple whammy' • Metoprolol: why it's no longer first-line for plain high blood pressure, and who still needs it • The FDA boxed warning: never stop a beta-blocker suddenly • Dizziness on standing, falls, and whether morning or evening dosing matters (TIME trial) • Seven questions to ask your doctor or pharmacist ⏱️ TIMESTAMPS 0:00 Three pills, millions of people 3:15 Why blood pressure matters more after 60 4:36 Three families of medicine 5:56 The biggest head-to-head study 7:38 Amlodipine and the swelling cascade 9:54 Lisinopril and the cough nobody connects 12:10 Metoprolol: no longer first choice 14:23 Never stop metoprolol suddenly 15:31 The side effect all three share 17:20 So which is safer for you? 19:00 The questions to ask your doctor 20:21 What happened to Harold and Betty 22:14 Your blood pressure checklist 📚 RESEARCH & REFERENCES 1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997. 2. Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. Hypertension / Journal of the American College of Cardiology. 2025. 3. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial (SPRINT). JAMA. 2016;315(24):2673–2682. 4. Lindholm LH, Carlberg B, Samuelsson O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. The Lancet. 2005;366(9496):1545–1553. 5. Savage RD, Visentin JD, Bronskill SE, et al. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Internal Medicine. 2020;180(5):643–651. 6. Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study). The Lancet. 2022;400(10361):1417–1425. 7. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525. 8. US Food and Drug Administration / DailyMed. Norvasc (amlodipine besylate) prescribing information (edema by dose). https://dailymed.nlm.nih.gov 9. US Food and Drug Administration / DailyMed. Metoprolol succinate and metoprolol tartrate prescribing information (boxed warning: ischemic heart disease and abrupt cessation). https://dailymed.nlm.nih.gov 10. US Food and Drug Administration / DailyMed. Lisinopril prescribing information (angioedema, hyperkalemia, cough). https://dailymed.nlm.nih.gov The people in this video's stories are composites, built from patterns described in the research, not real patients. ⚠️ MEDICAL DISCLAIMER This video is for educational and informational purposes only and is not medical advice, diagnosis or treatment. Never stop, start or change a medication, or make major changes to your diet or exercise, without speaking to your doctor or a qualified healthcare professional who knows your history. In an emergency, call your local emergency number. 💬 Tell us in the comments: your first name, your age, and where you're watching from. 🔔 Subscribe to Vital Years Project for clear, research-based health guidance for adults over 60. #BloodPressure #Hypertension #SeniorHealth #HealthyAging #Over60